Advertisement

Topics

Latest "Ludger Ltd" News Stories

06:07 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "Ludger Ltd" found in our extensive news archives from over 250 global news sources.

More Information about Ludger Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Ludger Ltd for you to read. Along with our medical data and news we also list Ludger Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of Ludger Ltd Companies for you to search.

Showing "Ludger" News Articles, all 22

Thursday 21st June 2018

Park Systems, leading Manufacturer of Atomic Force Microscopes Continues Global Expansion with ...

"We are excited to add both CN Tech and AVBA to help meet the growing demand for modern AFM technology in Europe," comments Ludger Read more...


Curetis Reports Results of the Annual General Meeting Held on June 21, 2018

Curetis / Curetis Reports Results of the Annual General Meeting Held on June 21, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Reports Results of the Annual General Meeting Held on June 21, 2018 - All proposed AGM resolutions approved by shareholders Amsterdam, the Netherlands, Holzge...

Tuesday 12th June 2018

Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018

Curetis / Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018 Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen, Germany...


Thursday 7th June 2018

Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.

Curetis / Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S. . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S. Multiple scientific conference cont...

Friday 18th May 2018

Curetis Publishes Business and Financial Update for the First Quarter 2018

Curetis / Curetis Publishes Business and Financial Update for the First Quarter 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Publishes Business and Financial Update for the First Quarter 2018 - Received U.S. FDA clearance for Unyvero System and LRT Cartridge - Grew revenues in EMEA ...

Wednesday 9th May 2018

Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018

Curetis / Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018 Amsterdam, the Netherlands, Holzgerlingen, Germany and San Diego, CA, USA, May 9, 2018, 07:...

Monday 30th April 2018

Curetis Announces Change of the Composition of Its Supervisory Board

Curetis / Curetis Announces Change of the Composition of Its Supervisory Board . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Announces Change of the Composition of Its Supervisory Board Dr. Holger Reithinger resigns as member of the Supervisory Board Company exploring options to fu...

Friday 27th April 2018

Curetis to Raise EUR 4.1 Million in Equity Offering with Access to Additional USD 10 million in Equity Over 36 Months

Curetis / Curetis to Raise EUR 4.1 Million in Equity Offering with Access to Additional USD 10 million in Equity Over 36 Months . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. THIS DOCUMENT MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA O...

Monday 23rd April 2018

Curetis to Publish its 2017 Annual Results on April 30, 2018

Curetis / Curetis to Publish its 2017 Annual Results on April 30, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis to Publish its 2017 Annual Results on April 30, 2018 - Company to host earnings conference call and webcast Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen...

Thursday 19th April 2018

Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018

Curetis / Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018 UTI panel covers 103 diagnostic targets 443-patien...

Wednesday 18th April 2018

Curetis: Novel Products and Study Data to be Presented at ECCMID 2018

Curetis / Curetis: Novel Products and Study Data to be Presented at ECCMID 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis: Novel Products and Study Data to be Presented at ECCMID 2018 Introduction of Unyvero UTI Application Cartridge Update on A30 RQ Analyzer to be provided MGI...

Wednesday 4th April 2018

Curetis' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority

Curetis / Curetis' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority Second market aut...

Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today

Curetis / Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo ...

Tuesday 3rd April 2018

Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge

Curetis / Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartr...

Monday 26th March 2018

Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018

Curetis / Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018 Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen, Germa...

Wednesday 14th March 2018

Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology

Curetis / Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.  Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology  IP position strengthened in the U.S. Patent supports utilit...

Thursday 8th March 2018

B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG successfully concludes second Annual General Meeting as a stock listed company

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): AGM/EGM 08.03.2018 / 16:26 The issuer is solely responsible for the content of this announcement. BRAIN AG successfully concludes second Annual General Meeting as a stock listed company Broad majorities for discharging Management Board and Supervisory Board New Supervisory Board member elected by...

Tuesday 6th March 2018

Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley

Curetis / Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley Award winner in "GoSiliconValley" competition by Austrian Economic Chambers Support fo...

Thursday 15th February 2018

#jobs #lifescience Ludger Ltd: Marie Curie Early Stage Researcher

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ludger Ltd: Marie Curie Early Stage Researcher . Standard Marie Curie ITN salary with benefits: Ludger Ltd: Exciting and ambitious PhD studentship in biopharmaceutical glycosylation analysis. Abingdon, Oxfordshire … Continue reading → Cet article #jobs #lifescience...

Tuesday 13th February 2018

Park Systems Holds Grand Opening Ceremony of the Park Nanoscience Lab at their European Headquarters

"The European scientific community plays a critical role in expanding cutting-edge science and research across many industries, particularly at the nanoscale," commented Ludger Weisser, Read more...

Tuesday 6th February 2018

Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test

Curetis / Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response...

Monday 5th February 2018

Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017

Curetis / Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces N...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks